Clearstate Pte. Ltd.
and
United BioSource Corporation (UBC)
announced a strategic partnership to provide global market access, pricing, and reimbursement strategies for manufacturers of biopharmaceuticals, medical devices, and other medical technology.
The agreement reinforces Clearstate’s position as a source for accurate and actionable market intelligence across the Asia-Pacific region and builds upon UBC’s leadership in delivering global market access strategies for life science products. The alliance provides UBC and its clients with access to the high quality market access, pricing, and reimbursement information.
Telemedicine Considerations When Conducting Decentralized Clinical Trials
January 14th 2025Compliance with state telemedicine requirements is imperative, as not only will most clinical trial sponsors contractually require such compliance, but non-compliance may also subject the practitioner to licensure violations and liability.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.